Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078341514> ?p ?o ?g. }
- W2078341514 endingPage "1420" @default.
- W2078341514 startingPage "1413" @default.
- W2078341514 abstract "1. Previous studies have provided evidence that activation of beta-adrenoceptors on cholinergic nerve terminals can inhibit neurotransmission in the airways. However, in most cases, this conclusion has been based on indirect evidence obtained from mechanical experiments where changes in airways smooth muscle tone were measured. 2. We have assessed whether modulation of cholinergic neurotransmission by beta-adrenoceptor agonists is due to a pre- or post-junctional action by investigating the effect of isoprenaline on contractile responses evoked by exogenous acetylcholine (ACh) and electrical field stimulation (EFS; 4 Hz, 40 V, 0.5 ms pulse width every 15 s), and on EFS-induced ACh release from cholinergic nerves innervating guinea-pig and human trachea. Furthermore, the subtype of beta-adrenoceptor which modulates neurotransmission and the potential role of cyclic AMP in this response were evaluated. 3. In guinea-pig trachea, isoprenaline (1 nM-1 microM) inhibited the contractile response evoked by exogenous ACh (1 microM) to a similar extent to that evoked by EFS (EC50 = 19.9 and 23 nM, respectively). 4. In epithelium-denuded guinea-pig strips treated with indomethacin (10 microM), isoprenaline significantly enhanced EFS-induced ACh release from cholinergic nerve terminals (by 36% at 0.3 microM). This effect was blocked by propranolol and ICI 118, 551 (each 0.1 microM). In contrast, isoprenaline failed to affect EFS-induced ACh release from parasympathetic nerves innervating human trachea. 5. To evaluate the role of cyclic AMP in the beta-adrenoceptor-induced facilitation of cholinergic neurotransmission, the effects of various cyclic AMP elevating drugs on ACh release were studied. Forskolin (10 microM) significantly augmented (by 17%) EFS-induced ACh release, an effect which was not reproduced by 1,9-dideoxyforskolin (10 microM) which does not activate adenylyl cyclase. Similarly, the cyclic AMP analogue, 8-bromo-cyclic AMP (1 mM) and cholera toxin (1 microgram ml-1) facilitated ACh output by 22 and 47% respectively, whereas prostaglandin E2 (PGE2, 0.1 nM-1 microM) inhibited this response (by 67% at 1 microM). 6. Zardaverine (10 microM), a dual inhibitor of the phosphodiesterase (PDE)3 and PDE4 isoenzyme families, did not affect EFS-induced ACh release and failed to facilitate the actions of either isoprenaline or PGE2. Similarly, neither SK&F 94120 (10 microM) nor rolipram (10 microM), selective inhibitors of PDE3 and PDE4 respectively, significantly affected the release of ACh in response to EFS. 7. The result of this study suggests that isoprenaline facilitates cholinergic neurotransmission in guinea-pig, but not human, trachea by activation of pre-junctional beta 2-adrenoceptors, an effect that may be mediated via activation of the cyclic AMP/cyclic AMP-dependent protein kinase cascade. Furthermore, the data presented herein illustrate the need to undertake direct measurements of neurotransmitter release when examining the effect of agents purported to act pre-junctionally." @default.
- W2078341514 created "2016-06-24" @default.
- W2078341514 creator A5006299446 @default.
- W2078341514 creator A5018753336 @default.
- W2078341514 creator A5022459918 @default.
- W2078341514 creator A5030258071 @default.
- W2078341514 creator A5076686230 @default.
- W2078341514 date "1996-04-01" @default.
- W2078341514 modified "2023-09-30" @default.
- W2078341514 title "Paradoxical facilitation of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by isoprenaline" @default.
- W2078341514 cites W1540948539 @default.
- W2078341514 cites W154829778 @default.
- W2078341514 cites W1945300947 @default.
- W2078341514 cites W1965237480 @default.
- W2078341514 cites W1965361554 @default.
- W2078341514 cites W1968538489 @default.
- W2078341514 cites W1971059677 @default.
- W2078341514 cites W1975800340 @default.
- W2078341514 cites W1976040256 @default.
- W2078341514 cites W1976707393 @default.
- W2078341514 cites W1977982645 @default.
- W2078341514 cites W1978307867 @default.
- W2078341514 cites W1991675805 @default.
- W2078341514 cites W1995062841 @default.
- W2078341514 cites W2010587283 @default.
- W2078341514 cites W2017756679 @default.
- W2078341514 cites W2018036643 @default.
- W2078341514 cites W2018097537 @default.
- W2078341514 cites W2023433805 @default.
- W2078341514 cites W2026530040 @default.
- W2078341514 cites W2028649427 @default.
- W2078341514 cites W2030657783 @default.
- W2078341514 cites W2035889897 @default.
- W2078341514 cites W2036117434 @default.
- W2078341514 cites W2038151405 @default.
- W2078341514 cites W2047316488 @default.
- W2078341514 cites W2054522876 @default.
- W2078341514 cites W2056984611 @default.
- W2078341514 cites W2067491611 @default.
- W2078341514 cites W2069298474 @default.
- W2078341514 cites W2083407012 @default.
- W2078341514 cites W2084299065 @default.
- W2078341514 cites W2086910429 @default.
- W2078341514 cites W2092227943 @default.
- W2078341514 cites W2109041953 @default.
- W2078341514 cites W2127349384 @default.
- W2078341514 cites W2168666363 @default.
- W2078341514 cites W2175156825 @default.
- W2078341514 cites W2259970314 @default.
- W2078341514 cites W2281796551 @default.
- W2078341514 cites W2283829605 @default.
- W2078341514 cites W2285843642 @default.
- W2078341514 cites W2296445887 @default.
- W2078341514 cites W2409349323 @default.
- W2078341514 cites W2418410822 @default.
- W2078341514 cites W2435561270 @default.
- W2078341514 cites W34045832 @default.
- W2078341514 doi "https://doi.org/10.1111/j.1476-5381.1996.tb15300.x" @default.
- W2078341514 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1909463" @default.
- W2078341514 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8730733" @default.
- W2078341514 hasPublicationYear "1996" @default.
- W2078341514 type Work @default.
- W2078341514 sameAs 2078341514 @default.
- W2078341514 citedByCount "42" @default.
- W2078341514 countsByYear W20783415142012 @default.
- W2078341514 countsByYear W20783415142013 @default.
- W2078341514 countsByYear W20783415142014 @default.
- W2078341514 countsByYear W20783415142015 @default.
- W2078341514 countsByYear W20783415142016 @default.
- W2078341514 countsByYear W20783415142017 @default.
- W2078341514 countsByYear W20783415142019 @default.
- W2078341514 countsByYear W20783415142022 @default.
- W2078341514 crossrefType "journal-article" @default.
- W2078341514 hasAuthorship W2078341514A5006299446 @default.
- W2078341514 hasAuthorship W2078341514A5018753336 @default.
- W2078341514 hasAuthorship W2078341514A5022459918 @default.
- W2078341514 hasAuthorship W2078341514A5030258071 @default.
- W2078341514 hasAuthorship W2078341514A5076686230 @default.
- W2078341514 hasBestOaLocation W20783415142 @default.
- W2078341514 hasConcept C126322002 @default.
- W2078341514 hasConcept C134018914 @default.
- W2078341514 hasConcept C170493617 @default.
- W2078341514 hasConcept C185592680 @default.
- W2078341514 hasConcept C200170125 @default.
- W2078341514 hasConcept C22885893 @default.
- W2078341514 hasConcept C24998067 @default.
- W2078341514 hasConcept C2775910092 @default.
- W2078341514 hasConcept C2776090920 @default.
- W2078341514 hasConcept C2776219046 @default.
- W2078341514 hasConcept C2778151854 @default.
- W2078341514 hasConcept C2778815084 @default.
- W2078341514 hasConcept C71924100 @default.
- W2078341514 hasConcept C86803240 @default.
- W2078341514 hasConceptScore W2078341514C126322002 @default.
- W2078341514 hasConceptScore W2078341514C134018914 @default.
- W2078341514 hasConceptScore W2078341514C170493617 @default.
- W2078341514 hasConceptScore W2078341514C185592680 @default.
- W2078341514 hasConceptScore W2078341514C200170125 @default.